DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes

JAMA Neurology

Volumn 71, Issue 2, 2014, Pages 208-215

  Caroppo, Paola ^a,b,c   Le Ber, Isabelle ^a,b,c,d   Clot, Fabienne ^d   Rivaud Péchoux, Sophie ^a,b,c   Camuzat, Agnès ^a,b,c   De Septenville, Anne ^a,b,c   Boutoleau Bretonnière, Claire ^e   Mourlon, Vanessa ^d   Sauvée, Mathilde ^f   Lebouvier, Thibaud ^e   Bonnet, Anne Marie ^b,d   Levy, Richard ^a,b,c,g   Vercelletto, Martine ^e   Brice, Alexis ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; COGNITIVE DEFECT; DCTN1 GENE; DYSEXECUTIVE SYNDROME; DYSTONIA; FAMILY HISTORY; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; GAZE; GENE; HUMAN; MALE; MESENCEPHALON; MISSENSE MUTATION; MUSCLE RIGIDITY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PEDIGREE ANALYSIS; PERRY SYNDROME; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PEDIGREE; PHENOTYPE; POINT MUTATION; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84893828881     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.5100     Document Type: Article

References (39)

1. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55(1):97-105.
2. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009;132(pt 1):156-171.
3. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270-279.
4. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44(11):2015-2019.
5. Donker Kaat L, Boon AJ, Azmani A, et al. Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology. 2009;73(2):98-105.
6. de Yébenes JG, Sarasa JL, Daniel SE, Lees AJ. Familial progressive supranuclear palsy: description of a pedigree and review of the literature. Brain. 1995;118(pt 5):1095-1103.
7. Rojo A, Pernaute RS, Fontán A, et al. Clinical genetics of familial progressive supranuclear palsy. Brain. 1999;122(pt 7):1233-1245.
8. Choumert A, Poisson A, Honnorat J, et al. G303V tau mutation presenting with progressive supranuclear palsy-like features. Mov Disord. 2012;27(4):581-583.
9. Ogaki K, Li Y, Takanashi M, et al. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord. 2013;19(1):15-20.
10. Cannas A, Borghero G, Floris GL, et al. The p. A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms. Neurogenetics. 2013;14(2):161-166.
11. Le Ber I, Camuzat A, Guillot-Noel L, et al. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis. 2013;34(2):485-499.
12. Lesage S, Le Ber I, Condroyer C, et al; French Parkinson's Disease Genetics Study Group. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain. 2013;136(pt 2):385-391.
13. Ros R, Gómez Garre P, Hirano M, et al. Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Ann Neurol. 2005;57(5):634-641.
14. Farrer MJ, Hulihan MM, Kachergus JM, et al. DCTN1 mutations in Perry syndrome. Nat Genet. 2009;41(2):163-165.
15. Lechevalier B, Schupp C, Fallet-Bianco C, et al. Familial parkinsonian syndrome with athymhormia and hypoventilation [in French]. Rev Neurol (Paris). 1992;148(1):39-46.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading cognitive status of patients for the clinician. J Psych Res. 1975;12:189-198.
17. Mattis S. Dementia Rating Scale Professional Manual. Odessa, FL: Psychological Assessment Resources; 1973.
18. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988;38(6):900-903.
19. Grant DA, Berg EA. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. J Exp Psychol. 1948;38(4):404-411.
20. Thuillard F, Assal G. Données neuropsychologiques chez le sujet âge' normal. In: Habib M, Joanette Y, Puel M, eds. Démences et Syndromes Démentiels: Approche Neuropsy-chologique. Paris, France: Masson; 1991:125-133.
21. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-1626.
22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
23. Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL. Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol. 1975;32(2):108-113.
24. Perry TL, Wright JM, Berry K, Hansen S, Perry TL Jr. Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases. Neurology. 1990;40(12):1882-1887.
25. Purdy A, Hahn A, Barnett HJ, et al. Familial fatal Parkinsonism with alveolar hypoventilation and mental depression. Ann Neurol. 1979;6(6):523-531.
26. Roy EP III, Riggs JE, Martin JD, Ringel RA, Gutmann L. Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management. Neurology. 1988;38(4):637-639.
27. Bhatia KP, Daniel SE, Marsden CD. Familial parkinsonism with depression: a clinicopathological study. Ann Neurol. 1993;34(6):842-847.
28. Elibol B, Kobayashi T, Atac FB, et al. Familial Parkinsonism With Apathy, Depression and Central Hypoventilation (Perry's Syndrome): Mapping the Progress of Alzheimer's and Parkinson's Disease. New York, NY: Kluwer Academic/Plenum Publishers; 2002:285-290.
29. Tsuboi Y, Dickson DW, Nabeshima K, et al. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol. 2008;115(2):263-268.
30. Ohshima S, Tsuboi Y, Yamamoto A, et al. Autonomic failures in Perry syndrome with DCTN1 mutation. Parkinsonism Relat Disord. 2010;16(9):612-614.
31. Newsway V, Fish M, Rohrer JD, et al. Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure. Mov Disord. 2010;25(6):767-770.
32. Wider C, Dachsel JC, Farrer MJ, Dickson DW, Tsuboi Y, Wszolek ZK. Elucidating the genetics and pathology of Perry syndrome. J Neurol Sci. 2010;289(1-2):149-154.
33. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33(4):455-456.
34. Puls I, Oh SJ, Sumner CJ, et al. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol. 2005;57(5):687-694.
35. Münch C, Sedlmeier R, Meyer T, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63(4):724-726.
36. Münch C, Rosenbohm A, Sperfeld AD, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol. 2005;58(5):777-780.
37. Wider C, Wszolek ZK. Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome): a literature review. Parkinsonism Relat Disord. 2008;14(1):1-7.
38. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(pt 9):2456-2477.
39. Omoto M, Suzuki S, Ikeuchi T, et al. Autosomal dominant tauopathy with parkinsonism and central hypoventilation. Neurology. 2012;78(10):762-764.